These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV. Lu J, Xie F, Geng L, Shen W, Sui C, Yang J. Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706 [Abstract] [Full Text] [Related]
3. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma. Zhu HT, Liu RB, Liang YY, Hasan AME, Wang HY, Shao Q, Zhang ZC, Wang J, He CY, Wang F, Shao JY. Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012 [Abstract] [Full Text] [Related]
5. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma. Huang J, Zheng Y, Xiao X, Liu C, Lin J, Zheng S, Yang B, Ou Q. Dis Markers; 2020 Jun; 2020():5417598. PubMed ID: 32733618 [Abstract] [Full Text] [Related]
11. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study. Ji J, Wang H, Li Y, Zheng L, Yin Y, Zou Z, Zhou F, Zhou W, Shen F, Gao C. PLoS One; 2016 Jun; 11(4):e0153227. PubMed ID: 27070780 [Abstract] [Full Text] [Related]
14. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma. Kim SS, Baek GO, Ahn HR, Sung S, Seo CW, Cho HJ, Nam SW, Cheong JY, Eun JW. Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601 [Abstract] [Full Text] [Related]
15. Des-γ carboxyprothrombin may not be a good biomarker for hepatocellular carcinoma in those chronically infected with hepatitis B virus with basal core promoter double mutations (T^{1762}, A^{1764}), a prospective study. Li GJ, Chen QY, Harrison TJ, Wang XY, Hu LP, Yang QL, Li KW, Fang ZL. Cancer Biomark; 2017 Oct; 18(3):241-248. PubMed ID: 28085009 [Abstract] [Full Text] [Related]
16. Microarray analysis on the lncRNA expression profile in male hepatocelluar carcinoma patients with chronic hepatitis B virus infection. Niu J, Lin Y, Liu P, Yu Y, Su C, Wang X. Oncotarget; 2016 Nov 15; 7(46):76169-76180. PubMed ID: 27769059 [Abstract] [Full Text] [Related]
17. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma. Li J, Wang X, Tang J, Jiang R, Zhang W, Ji J, Sun B. Cell Physiol Biochem; 2015 Nov 15; 37(2):687-96. PubMed ID: 26356260 [Abstract] [Full Text] [Related]
18. Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma. Li N, Zhu Q, Yang C, Li F, Zhou Z, Lv Y, Sang J, Han Q, Liu Z. Tumour Biol; 2016 May 15; 37(5):6607-17. PubMed ID: 26643893 [Abstract] [Full Text] [Related]
19. Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma. Lou ZH, Xu KY, Qiao L, Su XQ, Ou-Yang Y, Miao LB, Liu F, Wang Y, Fu A, Ren XH, Huang JS, Li ZY, Bao JF. Front Biosci (Landmark Ed); 2022 Sep 27; 27(9):264. PubMed ID: 36224021 [Abstract] [Full Text] [Related]
20. Identification of long non-coding RNA ZFAS1 as a novel biomarker for diagnosis of HCC. Luo P, Liang C, Zhang X, Liu X, Wang Y, Wu M, Feng X, Tu J. Biosci Rep; 2018 Aug 31; 38(4):. PubMed ID: 29559565 [Abstract] [Full Text] [Related] Page: [Next] [New Search]